Risk factors for multidrug-resistant tuberculosis in Hong Kong

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 9, 2008, Pages 1065-1070

  Law, W S ^a,d   Yew, W W ^b   Leung, C Chiu ^a   Kam, K M ^c   Tam, C M ^a   Chan, C K ^a   Leung, C C ^a  

^a DEPARTMENT OF HEALTH   (Hong Kong)

^b GRANTHAM HOSPITAL   (Hong Kong)

^c DEPARTMENT OF HEALTH   (Hong Kong)

^d Wanchai Chest Clinic   (Hong Kong)

Author keywords

Hong Kong; Multidrug resistant; Risk factors; Tuberculosis

Indexed keywords

AMIKACIN; CAPREOMYCIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLINICAL FEATURE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROL GROUP; CONTROLLED STUDY; FEMALE; FINANCIAL MANAGEMENT; GROUPS BY AGE; HONG KONG; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; STRATIFICATION; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADULT; AGED; ANTITUBERCULAR AGENTS; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; EMIGRATION AND IMMIGRATION; FEMALE; HONG KONG; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; REGISTRIES; RISK FACTORS; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 51149083473     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. World Health Organization. WHO fact sheet 2002; Geneva, Switzerland: WHO, 2002: 104.
2. Pablos-Mendez A, Raviglione M C, Laszlo A, et al. Global surveillance for antituberculosis-drug resistance 1994-1997. N Engl J Med 1998; 338: 1641-1649.
3. Hong Kong Tuberculosis and Chest Service, Department of Health. Annual report of the Tuberculosis and Chest Service 2003. Part I: Appendix 1. Hong Kong SAR, China: Department of Health, 2003.
4. Kam K M, Yip C W, Tse L W, et al. Trends in multidrug-resistant Mycobacterium tuberculosis in relation to sputum smear positivity in Hong Kong, 1989-1999. Clin Infect Dis 2002; 34: 324-329.
5. Hong Kong Tuberculosis and Chest Service, Department of Health. Annual report of the Tuberculosis and Chest Service 2000. Part I: Appendix 19. Hong Kong SAR, China: Department of Health, 2000.
6. Hong Kong Tuberculosis and Chest Service, Department of Health. Annual report of the Tuberculosis and Chest Service 2001. Part 1: Appendix 19-20. Hong Kong SAR, China: Department of Health, 2001.
7. Faustini A, Hall A J, Perucci C A. Risk factors for multidrug-resistant tuberculosis in Europe: a systematic review. Thorax 2006; 61: 158-163.
8. Drobniewski F, Eltringham I, Graham C, Magee J G, Smith E G, Watt B. A national study of clinical and laboratory factors affecting the survival of patients with multiple drug-resistant tuberculosis in the UK. Thorax 2002; 57: 810-816.
9. Robert J, Trystram D, Truffit-Pernot C, Jarlier V. Multidrug-resistant tuberculosis: eight years of surveillance in France. Eur Respir J 2003; 22: 833-837.
10. Chaulet P, Raviglione M, Bustreo F. Epidemiology, control and treatment of multidrug-resistant tuberculosis. Drugs 1996; 52 (Suppl 2): 103-107.
11. Sharma S K, Turaga K K, Balamurugan A, et al. Clinical and genetic risk factors for the development of multidrug-resistant tuberculosis in non-HIV infected patients at a tertiary care center in India: a case-control study. Infect Genet Evol 2003; 3: 183-188.
12. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 3rd ed. WHO/CDS/TB2003.313. Geneva, Switzerland: WHO, 2003.
13. World Health Organization. Report of the meeting of the Global Task Force on XDR-TB, October 2006. Geneva, Switzerland: WHO, 2006.
14. Granich R M, Oh P, Lewis B, Porco T C, Flood J. Multidrug resistance among persons with tuberculosis in California, 1994-2003. JAMA 2005; 293: 2732-2739.
15. Moniruzzaman A, Elwood R K, Schulzer M, FitzGerald J M. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia. Int J Tuberc Lung Dis 2006; 10: 844-850.
16. Aziz M A, Wright A, Laszlo A, et al. WHO/International Union Against Tuberculosis and Lung Disease Global Project on Anti-tuberculosis Drug Resistance Surveillance. Epidemiology of anti-tuberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet 2006; 368: 2142-2154.
17. Census and Statistics Department. Hong Kong statistics. Hong Kong in figures. 2005 edition: transport, communications and tourism. Hong Kong: Census and Statistics Department. http://www.info.gov.hk/censtatd/eng/Accessed April 2008.
18. Dye C, Espinal M A, Watt C J, Mbiaga C, Williams B G. Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis 2002; 185: 1197-1202.
19. Chan-Yeung M, Kam K M, Leung C C, et al. Population-based prospective molecular and conventional epidemiological study of tuberculosis in Hong Kong. Respirology 2006; 11: 442-448.
20. Mishra P, Hansen E H, Sabroe S, Kafle K K. Socio-economic status and adherence to tuberculosis treatment: a case-control study in a district of Nepal. Int J Tuberc Lung Dis 2005; 9: 1134-1139.
21. Portero N J, Rubio Y M, Pasicatan M A. Socio-economic determinants of knowledge and attitudes about tuberculosis among the general population of Metro Manila, Philippines. Int J Tuberc Lung Dis 2002; 6: 301-306.
22. Nair D M, George A, Chacko K T. Tuberculosis in Bombay: new insights from poor urban patients. Health Policy Plan 1997; 12: 77-85.
23. Morozova I, Riekstina V, Sture G, Wells C, Leimane V. Impact of the growing HIV-1 epidemic on multidrug-resistant tuberculosis control in Latvia. Int J Tuberc Lung Dis 2003; 7: 903-906.
24. Conover C, Ridzon R, Valway S, et al. Outbreak of multidrug-resistant tuberculosis at a methadone treatment program. Int J Tuberc Lung Dis 2001; 5: 59-64.
25. Hannan M M, Peres H, Maltez F, et al. Investigation and control of a large outbrcak of multidrug-resistant tuberculosis at a central Lisbon hospital. J Hosp Infect 2001; 47: 91-97.
26. Fleming M F, Krupitsky E, Tsoy M, et al. Alcohol and drug use disorders, HIV status and drug resistance in a sample of Russian TB patients. Int J Tuberc Lung Dis 2006; 10: 565-570.
27. World Health Organization. Emergence of XDR-TB. Geneva, Switzerland: WHO, 2006. http://www.who.int/mediacentre/news/notes/2006/np23/en/ Accessed July 2008.
28. Yew W W, Tarn C M. DOTS and DOTS-plus in Hong Kong. Int J Tuberc Lung Dis 2003; 7: 99-100.